Skip to main content

Welkom bij St. Antonius Academie & Bohn Stafleu van Loghum

St. Antonius Academie heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen. Je kunt je links eenvoudig registreren. Met deze gegevens kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL. Heb je een vraag, neem dan contact op met René Schuwer.

Registreer

Om ook buiten de locaties van St. Antonius Academie, thuis bijvoorbeeld, van Mijn BSL gebruik te kunnen maken, moet u zich eenmalig registreren. Dit kan alleen vanaf een computer op een van de locaties van St. Antonius Academie.

Eenmaal geregistreerd kunt u thuis of waar ook ter wereld onbeperkt toegang krijgen tot Mijn BSL.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Top

23-04-2025 | Review

A literature review exploring whether meaningful change threshold estimates for patient-reported outcome (PRO) measures vary depending on baseline severity

Auteurs: Joel Sims, Andrew Trigg, Jessica Flynn, Aoife Lydon, Natasha Griffiths, Kim Cocks, Rob Arbuckle

Gepubliceerd in: Quality of Life Research

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

Meaningful change thresholds for patient-reported outcome (PRO) measures may differ according to patients’ baseline disease severity. This review aimed to explore methods used in the peer-reviewed literature to assess the relationship between baseline severity and meaningful change thresholds and the nature of this relationship.

Methods

A structured literature review was conducted to identify relevant abstracts published between 2018–2022 reporting estimation of PRO meaningful change thresholds by baseline disease severity. Methods to estimate thresholds and direction of the relationship with baseline severity were extracted.

Results

1029 abstracts were screened and 22 full-text articles were deemed eligible for inclusion in the review. All 22 articles reported meaningful change thresholds that were estimated by baseline severity. Nearly all studies (n = 21) used anchor-based methods and reported thresholds for improvement. Most studies (n = 19) used the baseline score of the PRO being examined to define baseline severity. Baseline severity dependency was often tested by repeating methods within baseline-stratified groups (n = 16). All studies reported at least one PRO score where meaningful change was dependent upon baseline severity. The direction of the relationship for improvement was predominately a larger meaningful change threshold for worse baseline severity (n = 21).

Conclusion

Methods used to assess baseline severity dependency for meaningful change thresholds vary, however most studies reviewed concluded that larger thresholds are warranted for worse baseline severity. Future work should explore how to distinguish true baseline severity dependency from statistical artifacts to ensure accurate interpretation of PROs in both clinical trials and clinical practice.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference United States Food and Drug Administration. (2022). Patient-focused drug development: Selecting, developing, or modifying fit-for purpose clinical outcome assessments. Guidance for industry, food and drug administration staff, and other stakeholders. DRAFT GUIDANCE. United States Food and Drug Administration. (2022). Patient-focused drug development: Selecting, developing, or modifying fit-for purpose clinical outcome assessments. Guidance for industry, food and drug administration staff, and other stakeholders. DRAFT GUIDANCE.
2.
go back to reference Reeve, B. B., Wyrwich, K. W., Wu, A. W., Velikova, G., Terwee, C. B., Snyder, C. F., Schwartz, C., Revicki, D. A., Moinpour, C. M., & McLeod, L. D. (2013). ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Quality of Life Research, 22, 1889–1905.PubMedCrossRef Reeve, B. B., Wyrwich, K. W., Wu, A. W., Velikova, G., Terwee, C. B., Snyder, C. F., Schwartz, C., Revicki, D. A., Moinpour, C. M., & McLeod, L. D. (2013). ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Quality of Life Research, 22, 1889–1905.PubMedCrossRef
3.
go back to reference United States Food and Drug Administration. (2023). Patient-focused drug development: Incorporating clinical outcome assessments into endpoints for regulatory decision-making. Guidance for industry, food and drug administration staff, and other stakeholders. DRAFT GUIDANCE. United States Food and Drug Administration. (2023). Patient-focused drug development: Incorporating clinical outcome assessments into endpoints for regulatory decision-making. Guidance for industry, food and drug administration staff, and other stakeholders. DRAFT GUIDANCE.
4.
go back to reference Ren, J., Bushmakin, A. G., Cislo, P. R., Abraham, L., Cappelleri, J. C., Dworkin, R. H., & Farrar, J. T. (2024). Meaningful within-patient change for clinical outcome assessments: model-based approach versus cumulative distribution functions. Journal of Biopharmaceutical Statistics, 13, 1–13. Ren, J., Bushmakin, A. G., Cislo, P. R., Abraham, L., Cappelleri, J. C., Dworkin, R. H., & Farrar, J. T. (2024). Meaningful within-patient change for clinical outcome assessments: model-based approach versus cumulative distribution functions. Journal of Biopharmaceutical Statistics, 13, 1–13.
5.
go back to reference Speck, R. M., Yu, R., Ford, J. H., Ayer, D. W., Bhandari, R., & Wyrwich, K. W. (2021). Psychometric validation and meaningful within-patient change of the migraine-specific quality of life questionnaire version 21 electronic patient-reported outcome in patients with episodic and chronic migraine. Headache: The Journal of Head and Face Pain, 61(3), 511–526.CrossRef Speck, R. M., Yu, R., Ford, J. H., Ayer, D. W., Bhandari, R., & Wyrwich, K. W. (2021). Psychometric validation and meaningful within-patient change of the migraine-specific quality of life questionnaire version 21 electronic patient-reported outcome in patients with episodic and chronic migraine. Headache: The Journal of Head and Face Pain, 61(3), 511–526.CrossRef
6.
go back to reference Lansdall, C. J., McDougall, F., Butler, L., Delmar, P., Pross, N., Qin, S., McLeod, L., Zhou, X., Kerchner, G., & Doody, R. (2023). Establishing clinically meaningful change on outcome assessments frequently used in trials of mild cognitive impairment due to Alzheimer’s disease. The journal of prevention of Alzheimer’s disease, 10(1), 9–18.PubMedCrossRef Lansdall, C. J., McDougall, F., Butler, L., Delmar, P., Pross, N., Qin, S., McLeod, L., Zhou, X., Kerchner, G., & Doody, R. (2023). Establishing clinically meaningful change on outcome assessments frequently used in trials of mild cognitive impairment due to Alzheimer’s disease. The journal of prevention of Alzheimer’s disease, 10(1), 9–18.PubMedCrossRef
7.
go back to reference Johnston, B. C., Ebrahim, S., Carrasco-Labra, A., Furukawa, T. A., Patrick, D. L., Crawford, M. W., Hemmelgarn, B. R., Schunemann, H. J., Guyatt, G. H., & Nesrallah, G. (2015). Minimally important difference estimates and methods: A protocol. British Medical Journal Open, 5(10), e007953. Johnston, B. C., Ebrahim, S., Carrasco-Labra, A., Furukawa, T. A., Patrick, D. L., Crawford, M. W., Hemmelgarn, B. R., Schunemann, H. J., Guyatt, G. H., & Nesrallah, G. (2015). Minimally important difference estimates and methods: A protocol. British Medical Journal Open, 5(10), e007953.
8.
go back to reference Cook, C. E. (2008). Clinimetrics corner: The minimal clinically important change score (MCID): A necessary pretense. Journal of Manual & Manipulative Therapy, 16(4), 82E-83E.CrossRef Cook, C. E. (2008). Clinimetrics corner: The minimal clinically important change score (MCID): A necessary pretense. Journal of Manual & Manipulative Therapy, 16(4), 82E-83E.CrossRef
9.
go back to reference de Vet, H. C., Foumani, M., Scholten, M. A., Jacobs, W. C., Stiggelbout, A. M., Knol, D. L., & Peul, W. C. (2015). Minimally important change values of a measurement instrument depend more on baseline values than on the type of intervention. Journal of Clinical Epidemiology, 68(5), 518–524.PubMedCrossRef de Vet, H. C., Foumani, M., Scholten, M. A., Jacobs, W. C., Stiggelbout, A. M., Knol, D. L., & Peul, W. C. (2015). Minimally important change values of a measurement instrument depend more on baseline values than on the type of intervention. Journal of Clinical Epidemiology, 68(5), 518–524.PubMedCrossRef
10.
go back to reference Sutherland, J. M., Albanese, C. M., Wing, K., Zhang, Y. J., Younger, A., Veljkovic, A., & Penner, M. (2021). Effect of patient demographics on minimally important difference of Ankle Osteoarthritis Scale among end-stage ankle arthritis patients. Foot & Ankle International, 42(5), 624–632.CrossRef Sutherland, J. M., Albanese, C. M., Wing, K., Zhang, Y. J., Younger, A., Veljkovic, A., & Penner, M. (2021). Effect of patient demographics on minimally important difference of Ankle Osteoarthritis Scale among end-stage ankle arthritis patients. Foot & Ankle International, 42(5), 624–632.CrossRef
11.
go back to reference Wang, Y.-C., Hart, D. L., Stratford, P. W., & Mioduski, J. E. (2011). Baseline dependency of minimal clinically important improvement. Physical Therapy, 91(5), 675–688.PubMedCrossRef Wang, Y.-C., Hart, D. L., Stratford, P. W., & Mioduski, J. E. (2011). Baseline dependency of minimal clinically important improvement. Physical Therapy, 91(5), 675–688.PubMedCrossRef
12.
go back to reference Chiarotto, A., Vanti, C., Cedraschi, C., Ferrari, S., Ostelo, R. W., & Pillastrini, P. (2016). Responsiveness and minimal important change of the pain self-efficacy questionnaire and short forms in patients with chronic low back pain. The Journal of Pain, 17(6), 707–718.PubMedCrossRef Chiarotto, A., Vanti, C., Cedraschi, C., Ferrari, S., Ostelo, R. W., & Pillastrini, P. (2016). Responsiveness and minimal important change of the pain self-efficacy questionnaire and short forms in patients with chronic low back pain. The Journal of Pain, 17(6), 707–718.PubMedCrossRef
13.
go back to reference Schuller, W., Ostelo, R. W., Janssen, R., & de Vet, H. C. (2014). The influence of study population and definition of improvement on the smallest detectable change and the minimal important change of the neck disability index. Health and Quality of Life Outcomes, 12, 1–7.CrossRef Schuller, W., Ostelo, R. W., Janssen, R., & de Vet, H. C. (2014). The influence of study population and definition of improvement on the smallest detectable change and the minimal important change of the neck disability index. Health and Quality of Life Outcomes, 12, 1–7.CrossRef
14.
go back to reference Terluin, B., Roos, E. M., Terwee, C. B., Thorlund, J. B., & Ingelsrud, L. H. (2021). Assessing baseline dependency of anchor-based minimal important change (MIC): Don’t stratify on the baseline score! Quality of Life Research, 30(10), 2773–2782.PubMedPubMedCentralCrossRef Terluin, B., Roos, E. M., Terwee, C. B., Thorlund, J. B., & Ingelsrud, L. H. (2021). Assessing baseline dependency of anchor-based minimal important change (MIC): Don’t stratify on the baseline score! Quality of Life Research, 30(10), 2773–2782.PubMedPubMedCentralCrossRef
15.
go back to reference Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71.PubMedPubMedCentralCrossRef Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71.PubMedPubMedCentralCrossRef
16.
go back to reference Alma, H., de Jong, C., Jelusic, D., Wittmann, M., Schuler, M., Kollen, B., Sanderman, R., Kocks, J., Schultz, K., & van der Molen, T. (2019). Baseline health status and setting impacted minimal clinically important differences in COPD: An exploratory study. Journal of clinical epidemiology, 116, 49–61.PubMedCrossRef Alma, H., de Jong, C., Jelusic, D., Wittmann, M., Schuler, M., Kollen, B., Sanderman, R., Kocks, J., Schultz, K., & van der Molen, T. (2019). Baseline health status and setting impacted minimal clinically important differences in COPD: An exploratory study. Journal of clinical epidemiology, 116, 49–61.PubMedCrossRef
17.
go back to reference Bahadır, S., Yuksel, S., Ayhan, S., Nabi, V., Vila-Casademunt, A., Obeid, I., Perez-Grueso, F. J. S., Acaroglu, E., Group, E. S. S. (2021). Variation of minimum clinically important difference by age, gender, baseline disability, and change of direction in adult spinal deformity population: Is it a constant value? World Neurosurgery, 146, e1171–e1176.PubMedCrossRef Bahadır, S., Yuksel, S., Ayhan, S., Nabi, V., Vila-Casademunt, A., Obeid, I., Perez-Grueso, F. J. S., Acaroglu, E., Group, E. S. S. (2021). Variation of minimum clinically important difference by age, gender, baseline disability, and change of direction in adult spinal deformity population: Is it a constant value? World Neurosurgery, 146, e1171–e1176.PubMedCrossRef
18.
go back to reference Baker, J. F., Katz, P., & Michaud, K. (2021). Defining minimum clinically important changes for the patient activity scale II. Arthritis Care & Research, 73(10), 1456–1460.CrossRef Baker, J. F., Katz, P., & Michaud, K. (2021). Defining minimum clinically important changes for the patient activity scale II. Arthritis Care & Research, 73(10), 1456–1460.CrossRef
19.
go back to reference Bauer-Staeb, C., Kounali, D.-Z., Welton, N. J., Griffith, E., Wiles, N. J., Lewis, G., Faraway, J. J., & Button, K. S. (2021). Effective dose 50 method as the minimal clinically important difference: Evidence from depression trials. Journal of Clinical Epidemiology, 137, 200–208.PubMedPubMedCentralCrossRef Bauer-Staeb, C., Kounali, D.-Z., Welton, N. J., Griffith, E., Wiles, N. J., Lewis, G., Faraway, J. J., & Button, K. S. (2021). Effective dose 50 method as the minimal clinically important difference: Evidence from depression trials. Journal of Clinical Epidemiology, 137, 200–208.PubMedPubMedCentralCrossRef
20.
go back to reference Beemster, T., Van Bennekom, C., van Velzen, J., Reneman, M., & Frings-Dresen, M. (2018). The interpretation of change score of the pain disability index after vocational rehabilitation is baseline dependent. Health and Quality of Life Outcomes, 16, 1–9.CrossRef Beemster, T., Van Bennekom, C., van Velzen, J., Reneman, M., & Frings-Dresen, M. (2018). The interpretation of change score of the pain disability index after vocational rehabilitation is baseline dependent. Health and Quality of Life Outcomes, 16, 1–9.CrossRef
21.
go back to reference Blanker, M. H., Alma, H. J., Devji, T. S., Roelofs, M., Steffens, M. G., & van der Worp, H. (2019). Determining the minimal important differences in the international prostate symptom score and overactive bladder questionnaire: Results from an observational cohort study in Dutch primary care. British Medical Journal Open, 9(12), e032795. Blanker, M. H., Alma, H. J., Devji, T. S., Roelofs, M., Steffens, M. G., & van der Worp, H. (2019). Determining the minimal important differences in the international prostate symptom score and overactive bladder questionnaire: Results from an observational cohort study in Dutch primary care. British Medical Journal Open, 9(12), e032795.
22.
go back to reference Boyer, C. W., Lee, I. E., & Tenan, M. S. (2022). All MCIDs are wrong, but some may be useful. Journal of Orthopaedic & Sports Physical Therapy, 52(6), 401–407.CrossRef Boyer, C. W., Lee, I. E., & Tenan, M. S. (2022). All MCIDs are wrong, but some may be useful. Journal of Orthopaedic & Sports Physical Therapy, 52(6), 401–407.CrossRef
23.
go back to reference Carton, P., & Filan, D. (2020). Defining the minimal clinically important difference in athletes undergoing arthroscopic correction of sports-related femoroacetabular impingement: The percentage of possible improvement. Orthopaedic Journal of Sports Medicine, 8(1), 2325967119894747.PubMedPubMedCentralCrossRef Carton, P., & Filan, D. (2020). Defining the minimal clinically important difference in athletes undergoing arthroscopic correction of sports-related femoroacetabular impingement: The percentage of possible improvement. Orthopaedic Journal of Sports Medicine, 8(1), 2325967119894747.PubMedPubMedCentralCrossRef
24.
go back to reference De Kleermaeker, F. G., Boogaarts, H. D., Meulstee, J., & Verhagen, W. I. (2019). Minimal clinically important difference for the Boston carpal tunnel questionnaire: New insights and review of literature. Journal of Hand Surgery (European Volume), 44(3), 283–289.PubMedCrossRef De Kleermaeker, F. G., Boogaarts, H. D., Meulstee, J., & Verhagen, W. I. (2019). Minimal clinically important difference for the Boston carpal tunnel questionnaire: New insights and review of literature. Journal of Hand Surgery (European Volume), 44(3), 283–289.PubMedCrossRef
25.
go back to reference Karmacharya, P., Stull, C., Stephens-Shields, A., Husni, M. E., Scher, J. U., Craig, E., Fitzsimmons, R., Reddy, S. M., Magrey, M. N., & Ogdie, A. (2023). Responsiveness and minimum clinically important difference in patient-reported outcome measures among patients with psoriatic arthritis: A prospective cohort study. Arthritis Care & Research, 75(10), 2182–2189.CrossRef Karmacharya, P., Stull, C., Stephens-Shields, A., Husni, M. E., Scher, J. U., Craig, E., Fitzsimmons, R., Reddy, S. M., Magrey, M. N., & Ogdie, A. (2023). Responsiveness and minimum clinically important difference in patient-reported outcome measures among patients with psoriatic arthritis: A prospective cohort study. Arthritis Care & Research, 75(10), 2182–2189.CrossRef
26.
go back to reference Kitchen, H., Seitz, C., Trigg, A., Aldhouse, N., Willgoss, T., Schmitz, H., Gater, A., Gerlinger, C., & Haberland, C. (2021). Patients’ and clinicians’ perspectives on item importance, scoring, and clinically meaningful differences for the endometriosis symptom diary (ESD) and endometriosis impact scale (EIS). Health and Quality of Life Outcomes, 19, 1–14.CrossRef Kitchen, H., Seitz, C., Trigg, A., Aldhouse, N., Willgoss, T., Schmitz, H., Gater, A., Gerlinger, C., & Haberland, C. (2021). Patients’ and clinicians’ perspectives on item importance, scoring, and clinically meaningful differences for the endometriosis symptom diary (ESD) and endometriosis impact scale (EIS). Health and Quality of Life Outcomes, 19, 1–14.CrossRef
27.
go back to reference Kounali, D., Button, K. S., Lewis, G., Gilbody, S., Kessler, D., Araya, R., Duffy, L., Lanham, P., Peters, T. J., & Wiles, N. (2022). How much change is enough? Evidence from a longitudinal study on depression in UK primary care. Psychological Medicine, 52(10), 1875–1882.PubMedCrossRef Kounali, D., Button, K. S., Lewis, G., Gilbody, S., Kessler, D., Araya, R., Duffy, L., Lanham, P., Peters, T. J., & Wiles, N. (2022). How much change is enough? Evidence from a longitudinal study on depression in UK primary care. Psychological Medicine, 52(10), 1875–1882.PubMedCrossRef
28.
go back to reference Lapin, B., Thompson, N. R., Schuster, A., & Katzan, I. L. (2019). Clinical utility of patient-reported outcome measurement information system domain scales: Thresholds for determining important change after stroke. Circulation: Cardiovascular Quality and Outcomes, 12(1), e004753.PubMed Lapin, B., Thompson, N. R., Schuster, A., & Katzan, I. L. (2019). Clinical utility of patient-reported outcome measurement information system domain scales: Thresholds for determining important change after stroke. Circulation: Cardiovascular Quality and Outcomes, 12(1), e004753.PubMed
29.
go back to reference Malavolta, E. A., Yamamoto, G. J., Bussius, D. T., Assunção, J. H., Andrade-Silva, F. B., Gracitelli, M. E., & Neto, A. A. F. (2022). Establishing minimal clinically important difference for the UCLA and ASES scores after rotator cuff repair. Orthopaedics & Traumatology: Surgery & Research, 108(2), 102894. Malavolta, E. A., Yamamoto, G. J., Bussius, D. T., Assunção, J. H., Andrade-Silva, F. B., Gracitelli, M. E., & Neto, A. A. F. (2022). Establishing minimal clinically important difference for the UCLA and ASES scores after rotator cuff repair. Orthopaedics & Traumatology: Surgery & Research, 108(2), 102894.
30.
go back to reference McClure, N. S., Al Sayah, F., Ohinmaa, A., & Johnson, J. A. (2018). Minimally important difference of the EQ-5D-5L index score in adults with type 2 diabetes. Value in Health, 21(9), 1090–1097.PubMedCrossRef McClure, N. S., Al Sayah, F., Ohinmaa, A., & Johnson, J. A. (2018). Minimally important difference of the EQ-5D-5L index score in adults with type 2 diabetes. Value in Health, 21(9), 1090–1097.PubMedCrossRef
31.
go back to reference Riepe, C., Osada, N., Reich, A., Augustin, M., Zeidler, C., & Ständer, S. (2019). Minimal clinically important difference in chronic pruritus appears to be dependent on baseline itch severity. Acta Dermato-Venereologica, 99(13), 1288–1290.PubMedCrossRef Riepe, C., Osada, N., Reich, A., Augustin, M., Zeidler, C., & Ständer, S. (2019). Minimal clinically important difference in chronic pruritus appears to be dependent on baseline itch severity. Acta Dermato-Venereologica, 99(13), 1288–1290.PubMedCrossRef
32.
go back to reference Silverberg, J. I., Lei, D., Yousaf, M., Janmohamed, S., Vakharia, P., Chopra, R., Chavda, R., Gabriel, S., Patel, K., & Singam, V. (2021). What are the best endpoints for eczema area and severity index and scoring atopic dermatitis in clinical practice? A prospective observational study. British Journal of Dermatology, 184(5), 888–895.PubMedCrossRef Silverberg, J. I., Lei, D., Yousaf, M., Janmohamed, S., Vakharia, P., Chopra, R., Chavda, R., Gabriel, S., Patel, K., & Singam, V. (2021). What are the best endpoints for eczema area and severity index and scoring atopic dermatitis in clinical practice? A prospective observational study. British Journal of Dermatology, 184(5), 888–895.PubMedCrossRef
33.
go back to reference Stienstra, M., Edelaar, M., Fritz, B., & Reneman, M. (2022). Measurement properties of the work ability score in sick-listed workers with chronic musculoskeletal pain. Journal of Occupational Rehabilitation, 32(1), 103–113.PubMedCrossRef Stienstra, M., Edelaar, M., Fritz, B., & Reneman, M. (2022). Measurement properties of the work ability score in sick-listed workers with chronic musculoskeletal pain. Journal of Occupational Rehabilitation, 32(1), 103–113.PubMedCrossRef
34.
go back to reference Sutherland, J. M., Albanese, C. M., Crump, T., Liu, G., & Karimuddin, A. (2021). The minimally important difference of the gastrointestinal quality of life index for symptomatic gallstone surgery. Surgical Endoscopy, 35, 1–11.CrossRef Sutherland, J. M., Albanese, C. M., Crump, T., Liu, G., & Karimuddin, A. (2021). The minimally important difference of the gastrointestinal quality of life index for symptomatic gallstone surgery. Surgical Endoscopy, 35, 1–11.CrossRef
35.
go back to reference Zhou, L., Natarajan, M., Miller, B. S., & Gagnier, J. J. (2018). Establishing minimal important differences for the VR-12 and SANE scores in patients following treatment of rotator cuff tears. Orthopaedic Journal of Sports Medicine, 6(7), 2325967118782159.PubMedPubMedCentralCrossRef Zhou, L., Natarajan, M., Miller, B. S., & Gagnier, J. J. (2018). Establishing minimal important differences for the VR-12 and SANE scores in patients following treatment of rotator cuff tears. Orthopaedic Journal of Sports Medicine, 6(7), 2325967118782159.PubMedPubMedCentralCrossRef
36.
go back to reference McVary, K., Rogers, T., Cantrill, C., & Roehrborn, C. (2019). MP01-02 what minimal important difference in urinary symptom relief benefits patient quality of life?–Associated with Rezūm water vapor thermal therapy 4 year outcomes. Journal of Urology, 201, e1. McVary, K., Rogers, T., Cantrill, C., & Roehrborn, C. (2019). MP01-02 what minimal important difference in urinary symptom relief benefits patient quality of life?–Associated with Rezūm water vapor thermal therapy 4 year outcomes. Journal of Urology, 201, e1.
37.
go back to reference Terluin, B., Terwee, C., & Eekhout, I. (2022). Minimal clinically important difference estimates are biased by adjusting for baseline severity, not by regression to the mean. Journal of Athletic Training, 57(11–12), 1122–1123.PubMedCrossRef Terluin, B., Terwee, C., & Eekhout, I. (2022). Minimal clinically important difference estimates are biased by adjusting for baseline severity, not by regression to the mean. Journal of Athletic Training, 57(11–12), 1122–1123.PubMedCrossRef
39.
go back to reference Vander Weele, T. J. (2012). Confounding and effect modification: Distribution and measure. Epidemiological Methods, 1(1), 55–82. Vander Weele, T. J. (2012). Confounding and effect modification: Distribution and measure. Epidemiological Methods, 1(1), 55–82.
40.
go back to reference McDonald, R. P. (2013). Test theory: A unified treatment. London: Psychology Press.CrossRef McDonald, R. P. (2013). Test theory: A unified treatment. London: Psychology Press.CrossRef
42.
go back to reference Collister, D., Bangdiwala, S., Walsh, M., Mian, R., Lee, S. F., Furukawa, T. A., & Guyatt, G. (2021). Patient reported outcome measures in clinical trials should be initially analyzed as continuous outcomes for statistical significance and responder analyses should be reserved as secondary analyses. Journal of Clinical Epidemiology, 134, 95–102.PubMedCrossRef Collister, D., Bangdiwala, S., Walsh, M., Mian, R., Lee, S. F., Furukawa, T. A., & Guyatt, G. (2021). Patient reported outcome measures in clinical trials should be initially analyzed as continuous outcomes for statistical significance and responder analyses should be reserved as secondary analyses. Journal of Clinical Epidemiology, 134, 95–102.PubMedCrossRef
43.
go back to reference Terwee, C. B., Peipert, J. D., Chapman, R., Lai, J. S., Terluin, B., Cella, D., Griffiths, P., & Mokkink, L. B. (2021). Minimal important change (MIC): A conceptual clarification and systematic review of MIC estimates of PROMIS measures. Quality of Life Research, 30(10), 2729–2754.PubMedPubMedCentralCrossRef Terwee, C. B., Peipert, J. D., Chapman, R., Lai, J. S., Terluin, B., Cella, D., Griffiths, P., & Mokkink, L. B. (2021). Minimal important change (MIC): A conceptual clarification and systematic review of MIC estimates of PROMIS measures. Quality of Life Research, 30(10), 2729–2754.PubMedPubMedCentralCrossRef
44.
go back to reference Dworkin, R. H., Turk, D. C., Wyrwich, K. W., Beaton, D., Cleeland, C. S., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Kerns, R. D., Ader, D. N., Brandenburg, N., Burke, L. B., Cella, D., Chandler, J., Cowan, P., Dimitrova, R., Dionne, R., Hertz, S., Jadad, A. R., … Zavisic, S. (2008). Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. The Journal of Pain, 9(2), 105–121.PubMedCrossRef Dworkin, R. H., Turk, D. C., Wyrwich, K. W., Beaton, D., Cleeland, C. S., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Kerns, R. D., Ader, D. N., Brandenburg, N., Burke, L. B., Cella, D., Chandler, J., Cowan, P., Dimitrova, R., Dionne, R., Hertz, S., Jadad, A. R., … Zavisic, S. (2008). Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. The Journal of Pain, 9(2), 105–121.PubMedCrossRef
45.
go back to reference Vickers, A. J. (2001). The use of percentage change from baseline as an outcome in a controlled trial is statistically inefficient: A simulation study. BMC Medical Research Methodology, 1, 6.PubMedPubMedCentralCrossRef Vickers, A. J. (2001). The use of percentage change from baseline as an outcome in a controlled trial is statistically inefficient: A simulation study. BMC Medical Research Methodology, 1, 6.PubMedPubMedCentralCrossRef
46.
go back to reference Berry, D. A., & Ayers, G. D. (2006). Symmetrized percent change for treatment comparisons. The American Statistician, 60(1), 27–31.CrossRef Berry, D. A., & Ayers, G. D. (2006). Symmetrized percent change for treatment comparisons. The American Statistician, 60(1), 27–31.CrossRef
Metagegevens
Titel
A literature review exploring whether meaningful change threshold estimates for patient-reported outcome (PRO) measures vary depending on baseline severity
Auteurs
Joel Sims
Andrew Trigg
Jessica Flynn
Aoife Lydon
Natasha Griffiths
Kim Cocks
Rob Arbuckle
Publicatiedatum
23-04-2025
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-025-03982-3